Skip to main content
SpringerLink
Log in

Krebsprävention durch Vakzination

  • Chapter
Tumorerkrankungen

Part of the book series: Handbuch der Molekularen Medizin ((HDBMOLEK,volume 2))

  • 98 Accesses

Zusammenfassung

Infektionskrankheiten sind bis heute die Ursache für eine hohe Mortalität in Ländern der 3. Welt, in erster Linie bei Neugeborenen und Kindern. Nach Schätzungen der WHO waren 1990 in diesen Ländern 44% aller Todesfälle auf Infektionen mit Parasiten, Viren oder Bakterien (z. B. Malaria, HIV oder Tuberkulose) zurückzuführen [Mackett u. Williamson 1995], in westlichen Ländern waren es 4, 4%. Empirische Maßnahmen zur Verhütung von Infektionskrankheiten werden seit langem praktiziert. So führten die Isolierung der Erkrankten, die Beseitigung von vermeintlichen Infektionsquellen — z. B. die Schließung einer öffentlichen Wasserpumpe während der Choleraepidemie 1854 in London — bis hin zur allgemeinen Verbesserung der sanitären Verhältnisse häufig zur Eindämmung der Erkrankung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Altmann A, Gissmann L, Jochmus I (1994) Towards HPV vaccination. In: Minson A, Neil J, Mrae M (eds) Viruses and cancer. Cambridge University Press, Cambridge, pp 71–80

    Google Scholar 

  • Arbeit JM, Münger K, Howley PM, Hanahan D (1994) Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol 68: 4358–4364

    PubMed  CAS  Google Scholar 

  • Auewarakul P, Gissmann L, Cid A (1994) Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors. Mol Cell Biol 14: 8250–8258

    PubMed  CAS  Google Scholar 

  • Beasley RP, Lin CC, Hwang LT, Chein CS (1981) Hepatocellular carcinoma and hepatitis B virus. Lancet II: 1129–1133

    Google Scholar 

  • Bontkes HJ, Veenendal RA, Pea AS, Goedhard JG, Duijn W van, Kuiper I, Meijer JL, Lamers CBHW (1992) I subclass response to helicobacter pylori in patients with chronic active gastritis and duodenal ulcer. Scand J Gastroenterol 27: 129–133

    PubMed  CAS  Google Scholar 

  • Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 87: 796–802

    PubMed  CAS  Google Scholar 

  • Breitburd F, Kirnbauer R, Hubbert NL, Nonnenmacher B, Trindinhdesquarmet C, Orth G, Schiller JT, Lowy DR (1995) Immunization with virus like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol 69: 3 959–3963

    Google Scholar 

  • Buetow KH, Sheffield VC, Zhu M, Zhou T, Shen FM, Hino O, Smith M, Mahon BJ, Lanier AP, London WT (1992) Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas. Proc Natl Acad Sci USA 89: 9622–9626

    PubMed  CAS  Google Scholar 

  • Bukh J, Purcell RH, Miller RH (1993) At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative El gene of isolates collected worldwide. Proc Natl Acad Sci USA 90: 8234–8238

    PubMed  CAS  Google Scholar 

  • Campo MS (1994) Vaccination against papillomavirus in cattle. Current Top Microbiol Immunol 186: 255–266

    CAS  Google Scholar 

  • Cann AJ, Chen ISY (1996) Human T-cell leukemia virus types I and II. In: Fields B, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (eds) Virology, 3rd edn. Raven Press, New York, pp 1849–1880

    Google Scholar 

  • Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DA, Moore PS (1994) Identification of herpes virus-like DNA sequences in aids-associated Kaposis’ sarcoma. Science 266: 1865–1869

    PubMed  CAS  Google Scholar 

  • Chen DS (1993) From hepatitis to hepatoma: lessons from type B hepatitis. Science 262: 369–370 Chen M, Lee A, Hazell S, Hu P, Li Y (1993) Immunization against gastric infection with Helicobacter species: first step in the prophylaxis of gastric cancer? Zentralbl Hyg Umweltmed 280: 155–165

    CAS  Google Scholar 

  • Chien DY, Choo QL, Ralston R, Spaete R, Tong M, aHoughton M, Ku (1993) Persistence of HVC despite antibodies to both putative envelope glycoproteins. Lancet 342: 933

    PubMed  CAS  Google Scholar 

  • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a NA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359–362

    PubMed  CAS  Google Scholar 

  • Choo QL, Kuo G, Ralston B (1994) Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 91: 1294–1298

    PubMed  CAS  Google Scholar 

  • Chou WH, Yoneyama T, Takeuchi K, Harada H, Saito I, Miyamura T (1991) Discrimination of hepatitis C virus in liver tissue from patients with hepatocellular carcinoma by direct nucleotide sequence of amplified NA of the viral genome. J Clin Microbiol 29: 2860–2864

    PubMed  CAS  Google Scholar 

  • Ciuffo G (1907) Investo positi con filtrato di verucce volgare. Giornale Italiano Delle Malattie. Veneree 48: 12–17

    Google Scholar 

  • Cleary ML, Epstein MA, Finerty S, Dorfman RF, Bornkamm GW, Kirkwood JK, Morgan AJ, Sklar J (1985) Individual tumors of multifocal Epstein Barr virus induced malignant lymphomas in tamarins arise from different B cell clones. Science 228: 772–774

    Google Scholar 

  • Cobrinik D, Dowdy SF, Hinds PW, Mittnacht S, Weinberg RA (1992) The retinoblastoma protein and the regulation of cell cycling. TIBS 17: 312–315

    PubMed  CAS  Google Scholar 

  • Coursaget P, Yvonnet B, Chotard J, Sarr M, Vincelot P, N’Doye R, Diop-Mar I, Chiron JP (1986) Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senagal). Lancet II: 1143–1145

    Google Scholar 

  • Cross SL, Feinberg MB, Wolf JB, Holbrook NJ, Wong-Staal F, Leonhard WJ (1987) Regulation of the human interleu-kin-2 receptor alpha promoter; activation of a non-functional promoter by the transactivator gene of HTLV-I. Cell 49: 47–56

    PubMed  CAS  Google Scholar 

  • De Villiers EM (1989) Heterogeneity of the human papillomavirus group. J Virol 63: 4898–4903

    PubMed  Google Scholar 

  • Delius H, Hofmann B (1994) Primer-directed sequencing of human papillomavirus types. In: Zur Hausen H (ed) Human pathogenic papillomaviruses. Springer, Berlin Heidelberg New York, pp 13–31

    Google Scholar 

  • Dyson N, Howley PM, Münger K, Harlow E (1989) The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934–937

    PubMed  CAS  Google Scholar 

  • Eilermann V, Bang O (1908) Experimentelle Leukämie bei Hühnern. Zentralbl Bakteriol Mikrobiol Hyg 46: 595–599

    Google Scholar 

  • Ellis RW (1994) New technologies for making vaccines In: Plotkin SA, Mortimer EA (eds) Vaccines. Saunders, Philadelphia, pp 867–887

    Google Scholar 

  • Epstein MA, Morgan AJ (1986) Progress with subunit vaccines against the virus. In: Epstein MA, Achong BG (eds) The Epstein-Barr-virus. Recent advances. Heinemann, New York, pp 272–289

    Google Scholar 

  • Farci P, Purcell RH (1993) Natural history and experimental models. In: Zuckerman AJ, Thomas HC (eds) Viral hepatitis. Scientific basis and clinical management. Churchill Livingstone, Edinburgh London New York, pp 241–268

    Google Scholar 

  • Farci P, Alter HJ, Won DC (1994) Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 91: 7792–7796

    PubMed  CAS  Google Scholar 

  • Feitelson MA, Zhu M, Duan LX, London WT (1993) Hepatitis B virus x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8: 1109–1117

    PubMed  CAS  Google Scholar 

  • Finerty S, Tarlton J, Mackett M, Conway M, Arrand JR, Watkins PE, Morgan AJ (1992) Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector. J Gen Virol 73: 449–453

    PubMed  CAS  Google Scholar 

  • Forsyth DM (1969) A longitudinal study of endemic urinary schistosomiasis in a small East African community. Bull World Health Organ 40: 771–783

    PubMed  CAS  Google Scholar 

  • Geser AD, Thé G de, Lenoir G, Day NE, Williams EH (1982) Final case reporting from the Uganda prospective study of the relationship between EBV and Burkitt’s lymphoma. Int J Cancer 29: 397–400

    PubMed  CAS  Google Scholar 

  • Gu SY, Huang TM, Ruan L, Miao YH, Lu H, Chu CM, Motz M, Wolf H (1995) First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane protein. Dev Biol Stand 84: 171–177

    PubMed  CAS  Google Scholar 

  • Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T (1990) Epstein-Barr virus in patients with lethal midline granuloma. Lancet 335: 128–130

    PubMed  CAS  Google Scholar 

  • Harris C (1990) Hepatocellular carcinogenesis: recent advances and speculations. Cancer Cells 2: 146–148

    PubMed  CAS  Google Scholar 

  • Herbst H, Steinbrecher E, Niedobiteck G, Young LS, Brooks L, Müller-Lantzsch N, Stein H (1992) Distribution and phenotype of Epstein Barr virus harbouring cells in Hodgkin’s disease. Blood 80: 484–491

    PubMed  CAS  Google Scholar 

  • Hill MJ (1986) Microbes and human carcinogenesis. Arnold, London, pp 36–55

    Google Scholar 

  • Hilleman MR, Buynak EB, Roehm RR, Tytell AA, Bertland UA, Lampson GP (1975) Purified and inactivated human hepatitis B vaccine: progress report. Am J Med Sci 270: 401–404

    PubMed  CAS  Google Scholar 

  • Hinrichs SH, Nerenberg M, Reynolds K, Khoury G, Jay G (1987) A transgenic mouse model for human neurofibromatosis. Science 237: 1340–1343

    PubMed  CAS  Google Scholar 

  • Ho JHC (1972) Current knowledge of the epidemiology of nasopharyngeal carcinoma. In: Biggs P, Thé G de, Payne L (eds) Oncogenesis and herpes viruses. IARC, Lyon, pp 357–366

    Google Scholar 

  • Höhne M, Schaefer S, Seifer M, Feitelsen MA, Paul D, Gerrlich WH (1990) Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatits B virus. EMBO J 9: 1137–1145

    PubMed  Google Scholar 

  • Hollsberg P, Haller DA (1993) Pathogenesis of diseases induced by human lymphotropic virus type 1 infection. N Engl J Med 328: 1173–1182

    PubMed  CAS  Google Scholar 

  • Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) mutations in human cancers. Science 253: 49–53

    PubMed  CAS  Google Scholar 

  • Houghton M (1996) Hepatitis C virus. In: Fields B, Knipe DM, Howley PM, Chanock RM, Hirsch MS, Melnick JL, Monath TP, Roizman B (eds) Virology, 3rd edn. Raven Press, New York, pp 1035–1058

    Google Scholar 

  • Howley PH (1996) Papillomavirinae: the viruses and their replication. In: Fields B, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (eds) Virology, 3rd edn. Raven Press, New York, pp 2045–2076

    Google Scholar 

  • IARC monographs on the evaluation of carcinogenic risks to humans (1994a) Hepatitis viruses, vol 59. IARC, Lyon

    Google Scholar 

  • IARC monographs on the evaluation of carcinogenic risks to humans (1994b) Schistosomes, liver flukes and helicobacter pylori, vol 61. IARC, Lyon

    Google Scholar 

  • Iizuka N, Kohara M, Hagino-Yamagishi K, Abe S, Komatsu T, Tago K, Arita M, Nomoto A (1989) Construction of less neurovirolent polioviruses by introducing deletions into the 5’noncoding sequence of the genome. J Virol 63: 5354–5356

    PubMed  CAS  Google Scholar 

  • Ikenberg H (1991) Human papillomavirus DNA in invasive genital carcinomas. In: Gross G, Jablonska S, Pfister H, Stegner HE (eds) Genital papillomavirus infections. Springer, Berlin Heidelberg New York, pp 87–112

    Google Scholar 

  • Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC (1982) A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218: 571–573

    PubMed  CAS  Google Scholar 

  • Kastan MB, Zhan Q, Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD 45 is defective in ataxia teleangiectasia. Cell 71: 587–597

    PubMed  CAS  Google Scholar 

  • Kekule AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R (1990) The pr2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343: 457–461

    PubMed  CAS  Google Scholar 

  • Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider HP (1993) Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361: 742–745

    PubMed  CAS  Google Scholar 

  • Kiyosawa K, Sodeyama T, Tanaka E, Nakano Y, Furuta S, Nishioka K, Purcell RH, Alter HJ (1991) Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med 115: 367–369

    PubMed  CAS  Google Scholar 

  • Klingelhutz AJ, Foster SA, McDougall JK (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380: 79–82

    PubMed  CAS  Google Scholar 

  • Krugman S, Giles JP, Hammond J (1970) Hepatits C virus: effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strain. J Infect Dis 122: 432–436

    PubMed  CAS  Google Scholar 

  • Linke HK, Miller FH, Peterson D (1987) Documentation of non-A, non-B hepatitis in a chimpanzee with hepatocellular carcinoma. In: Robinson W, Koike K, Will H (eds) Hepadna viruses. Liss, New York, pp 357–370

    Google Scholar 

  • Mackett M, Williamson JD (1995) Human vaccines and vaccination. Bios Scientific Publishers, Oxford

    Google Scholar 

  • Marshall BJ (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet I: 1273–1275

    Google Scholar 

  • Maruyama I, Shibuya H, Harada H, Hatakeyama M, Seiki M, Fujita T, Inoue J, Yoshida M, Taniguchi T (1987) Evidence for aberrant activation of the interleukin-2 auto-krine loop by HTLV-I encoded p40xl and T3/Ti complex triggering. Cell 48: 343–350

    PubMed  CAS  Google Scholar 

  • Maupas P, Chiron JP, Barin F, Coursaget P, Goudeau A, Perrin J, Denis F, Diop-Mar I (1981) Efficacy of hepatitis B vaccine in prevention of early HBg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet I: 289–292

    Google Scholar 

  • McFaydan J, Hobday F (1898) Notes on the experimental transmission of warts in the dog. J Comp Pathol Ther 11: 342–346

    Google Scholar 

  • McMahon BJ, Rhoades ER, Heyward WL, Tower E, Ritter D, Lanier AP, Wainwright RB, Helminiak C (1987) A comprehensive program to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives. Lancet II: 1134–1136

    Google Scholar 

  • Miller RH, Purcell RH (1990) Hepatits C virus shares aminoacid sequence similarity with pestiviruses and flavi-viruses as well as members of two plant virus subgroups. Proc Natl Acad Sci USA 87: 2057–2061

    PubMed  CAS  Google Scholar 

  • Mondelli MU, Colombo M (1991) The emerging picture of hepatitis C. Dig Dis 9: 245–252

    PubMed  CAS  Google Scholar 

  • Morgan AJ (1992) Epstein-Barr virus vaccines. Vaccine 10: 563–571

    PubMed  CAS  Google Scholar 

  • Morgan AJ, Mackett M, Finerty S, Arrand JR, Scullion FT, Epstein MA (1988) Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cotton top tamarins against EB virus-induced malignant lymphomas. J Med Virol 25: 189–195

    PubMed  CAS  Google Scholar 

  • Murphy FA (1996) Virus taxonomy. In: Fields B, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (eds) Virology, 3rd edn. Raven Press, New York, pp 15–57

    Google Scholar 

  • Nagaya T, Nakamura T, Tokino T, Tsurimoto T, Imai M, Mayumi T, Kamino K, Yamamura K, Matsubura K (1987) The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev 1: 773–782

    PubMed  CAS  Google Scholar 

  • Nakamura H, Hayami M, Ohta Y, Ishikawa K, Tsujimoto H, Kiyokawa T, Yoshida M, Sasagawa A, Honjo S (1987) Pretection of cynomolgus monkeys against infection by human T cell leukemia virus type-I by immunization with viral env gene products produced in E. coli. Int J Cancer 40: 403–407

    CAS  Google Scholar 

  • Noach LA, Bosma NB, Jansen J, Haeck FJ, Deventer SJH van, Tytgat GNJ (1994) Mucosal tumor necrosis factor-a, in-terleukin-lß and interleukin-8 production in patients with helicobacter pylori infection. Scand J Gastroenterol 29: 425–429

    PubMed  CAS  Google Scholar 

  • Parkin DM, Laara E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41: 184–197

    PubMed  CAS  Google Scholar 

  • Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J (eds) (1992) Cancer incidence in five continents, vol VI. IARC scientific publications No. 120. IARC, Lyon, pp 182–193

    Google Scholar 

  • Payne LN (1994) Marek’s disease virus. In: Webster RG, Granoff A (eds) Encyclopedia of virology. Academic Press, New York London, pp 832–837

    Google Scholar 

  • Pel PK (1899) Ziekten van de Maag. De Erven F Bohn, Amsterdam

    Google Scholar 

  • Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415–7419

    PubMed  CAS  Google Scholar 

  • Popper H, Roth L, Purcell RH, Tennant BC, Gerin JL (1987) Hepatocarcinogenesis of the woodchuck hepatitis virus. Proc Natl Acad Sci USA 84: 866–870

    PubMed  CAS  Google Scholar 

  • Rickinson AB, Kieff E (1996) Epstein Barr virus. In: Fields B, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (eds) Virology, 3rd edn. Raven Press, New York, pp 2397–2446

    Google Scholar 

  • Rigoni-Stern D (1842) Fatti statistici relativi alle malatie cancerose. G Serv Prog Pathol Ther 2: 507–519

    Google Scholar 

  • Roden RBS, Hubbert NL, Kirnbauer R, Christensen ND, Lowy DR, Schiller JT (1996) Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J Virol 70: 3298–3301

    PubMed  CAS  Google Scholar 

  • Rous P (1911) A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13: 397–399

    PubMed  CAS  Google Scholar 

  • Rous P, Beard JW (1934) The progression to carcinoma of virus-induced rabbit papilloma (shope). J Exp Med 62: 523–528

    Google Scholar 

  • Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129–1136

    PubMed  CAS  Google Scholar 

  • Schiffman MH (1994) Epidemiology of cervical human papillomavirus infections. In: Zur Hausen H (ed) Human pathogenic papillomaviruses. Springer, Berlin Heidelberg New York, pp 55–81

    Google Scholar 

  • Schiller JT, Roden RBS (1995) Papillomavirus-like particles. Papillomavirus Rep 6: 121–128

    Google Scholar 

  • Schmuckler EA, Ferrell L, Clawson GA (1984) Proliferative hepatocellular lesions, benign and malignant. In: Vyas GN, Dienstag JL, Hoofnagle JH (eds) Viral hepatitis and liver disease. Grune & Stratton, New York, pp 201–207

    Google Scholar 

  • Seto A, Kawanishi M, Matsuda S, Ogawa K, Miyoshi I (1988) Adult T-cell leukemia-like disease experimentally induced in rabbits. Jpn J Cancer Res 79: 335–341

    PubMed  CAS  Google Scholar 

  • Shah KV, Howley PM (1996) Papillomaviruses. In: Fields B, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (eds) Virology, 3rd edn. Raven Press, New York, pp 2077–2110

    Google Scholar 

  • Shamanin V, Glover M, Rausch C, Proby C, Leigh IM, Zur Hausen H, Villiers EM de (1994) Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 54: 4610–4613

    PubMed  CAS  Google Scholar 

  • Shida H, Tochikura T, Sato T, Konno T, Hirayoshi K, Seki M, Ito Y, Hatanaka M, Hinuma Y, Sugimoto M (1987) Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I expression. EMBO J 6: 3379–3384

    PubMed  CAS  Google Scholar 

  • Sidebotham RL, Batten JJ, Karim QN, Spencer J, Baron JH (1991) Breakdown of gastric mucus in presence of helicobacter pylori. J Clin Pathol 44: 52–57

    PubMed  CAS  Google Scholar 

  • Simmonds P, Holmes EC, Cha TA, Chan SW, Mmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS (1993) Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74: 2391–2399

    PubMed  CAS  Google Scholar 

  • Snijders PJF, Brule AJC van den, Meijer CJLM, Walboomers JMM (1994) Papillomaviruses and cancer of the upper digestive and respiratory tracts. In: Zur Hausen H (ed) Human pathogenic papillomaviruses. Springer, Berlin Heidelberg New York, pp 177–198

    Google Scholar 

  • Sonnex C (1995) The clinical features of genital and perigenital human papillomavirus infection. In: Mindel A (ed) Genital warts: human papillomavirus infection. Arnold, London, pp 82–104

    Google Scholar 

  • The Gambia hepatitis study group (1987) The Gambia hepatitis intervention study. Cancer Res 47: 5782–5787

    Google Scholar 

  • Thé G de (1982) Epidemiology of Epstein Barr virus and associated diseases. In: Roizman B (ed) The herpesviruses, vol 1. Plenum Press, New York, pp 25–87

    Google Scholar 

  • Thé G de, Bomford R, Kazanji M, Ibrahim F (1994) Human T cell lymphotropic virus: necessity for and feasibility of a vaccine. Ciba Found Symp 187: 47–55

    PubMed  Google Scholar 

  • Thorey-Lawson DA, Geilinger K (1980) Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein Barr virus neutralize infectivity. Proc Natl Acad Sci USA 77: 3507–3511

    Google Scholar 

  • Tiollais P, Pourcel C, Dejean A (1985) The Hepatitis B virus. Nature 317: 489–495

    PubMed  CAS  Google Scholar 

  • Tur-kasta R, Burk RD, Shaul Y, Shafritz DA (1986) Hepatitis B virus DNA contains a glucocorticoid responsive element. Proc Natl Acad Sci USA 83: 1627–1631

    Google Scholar 

  • Ulmer JB, Donnelly J, Parker SE, Rhodes DH, Feigner PL, Dwarki VL, Grombowski SH, Deck R, Devitt CM, Friedman A, Hawe LA, Leander KR, Marinez D, Perry H, Shiver JW, Montgomery D, Liu MA (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745–1749

    PubMed  CAS  Google Scholar 

  • Vousden KH, Farrell PJ (1994) Viruses and human cancer. Br Med Bull 50: 560–581

    PubMed  CAS  Google Scholar 

  • Warren JR (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet I: 1273

    Google Scholar 

  • Whittle HC, Lamb WH, Ryder RW (1987) Trials of intradermal hepatitis B vaccines in Gambian children. Ann Trop Paediatr 7: 6–9

    PubMed  CAS  Google Scholar 

  • Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S (1991) Vaccination against hepatitis B and protection against chronic viral carriage in the Gambia. Lancet 337: 747–750

    PubMed  CAS  Google Scholar 

  • WHO (1993) The control of schistosomiasis. Second report of the WHO expert committee. WHO Tech Rep Ser 830

    Google Scholar 

  • Wolf H, Zur Hausen H, Becker Y (1973) EBV viral genomes in epithelial nasopharyngeal carcinoma cells. Nat Biol 244: 245–257

    CAS  Google Scholar 

  • Zerfaß K, Schulze A, Spitkovsky D, Friedman V, Henglein B, Jansen-Dürr P (1995) Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus 16 E7 through sequences necessary for transformation. J Virol 69: 6389–6399

    PubMed  Google Scholar 

  • Zur Hausen (1976) Condylomata acuminata and human genital cancer. Cancer Res 36: 794

    PubMed  Google Scholar 

  • Zur Hausen (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184: 9–13

    PubMed  Google Scholar 

  • Zur Hausen H, Schulte-Holthausen H, Klein G (1970) EBV DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature 228: 1956–1958

    Google Scholar 

Download references

Authors
  1. Lutz Gissmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Max-Delbrück-Centrum für Molekulare Medizin (MDC), Robert-Rössle-Str. 10, D-13122, Berlin-Buch, Deutschland

    Detlev Ganten  & Klaus Ruckpaul  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gissmann, L. (1998). Krebsprävention durch Vakzination. In: Ganten, D., Ruckpaul, K. (eds) Tumorerkrankungen. Handbuch der Molekularen Medizin, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80362-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-80362-8_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-80363-5

  • Online ISBN: 978-3-642-80362-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation